245 related articles for article (PubMed ID: 28411969)
1. Valproate-Induced Hyperammonemic Encephalopathy in General Hospital Patients With One or More Psychiatric Disorders.
Lewis C; Tesar GE; Dale R
Psychosomatics; 2017; 58(4):415-420. PubMed ID: 28411969
[TBL] [Abstract][Full Text] [Related]
2. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
Larsen EP; Ostergaard JR
Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
[TBL] [Abstract][Full Text] [Related]
3. Valproate (VPA)-associated hyperammonemic encephalopathy independent of elevated serum VPA levels: 21 cases in China from May 2000 to May 2012.
Cheng M; Tang X; Wen S; Yue J; Wang H
Compr Psychiatry; 2013 Jul; 54(5):562-7. PubMed ID: 23246073
[TBL] [Abstract][Full Text] [Related]
4. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.
Chopra A; Kolla BP; Mansukhani MP; Netzel P; Frye MA
Gen Hosp Psychiatry; 2012; 34(3):290-8. PubMed ID: 22305367
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting.
Kimmel RJ; Irwin SA; Meyer JM
Int Clin Psychopharmacol; 2005 Jan; 20(1):57-8. PubMed ID: 15602119
[TBL] [Abstract][Full Text] [Related]
6. Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
Vossler DG; Wilensky AJ; Cawthon DF; Kraemer DL; Ojemann LM; Caylor LM; Morgan JD
Epilepsia; 2002 Feb; 43(2):154-9. PubMed ID: 11903461
[TBL] [Abstract][Full Text] [Related]
7. Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.
Patel N; Landry KB; Fargason RE; Birur B
Psychopharmacol Bull; 2017 Jan; 47(1):40-44. PubMed ID: 28138203
[TBL] [Abstract][Full Text] [Related]
8. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
Fassi G; Igoa A; Liste OA
Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Presentation, and Risk Factors for Sodium Valproate-Associated Hyperammonemia in Neurosurgical Patients: A Prospective, Observational Study.
Woo PYM; Woo AWY; Lam SW; Ko NMW; Ho JWK; Chu ACH; Kwan MCL; Chan Y; Wong HT; Chan KY
World Neurosurg; 2020 Dec; 144():e597-e604. PubMed ID: 32916358
[TBL] [Abstract][Full Text] [Related]
10. Valproate-associated hyperammonemic encephalopathy.
Wadzinski J; Franks R; Roane D; Bayard M
J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
[TBL] [Abstract][Full Text] [Related]
11. Valproate-induced hyperammonemic encephalopathy: a case report.
Shah S; Wang R; Vieux U
J Med Case Rep; 2020 Jan; 14(1):19. PubMed ID: 31980035
[TBL] [Abstract][Full Text] [Related]
12. Valproate-induced hyperammonemic encephalopathy associated with urinary tract infection and urinary retention in the psychiatric setting.
Dawson LP; Lee SJ; Hollander YS
Aust N Z J Psychiatry; 2016 Nov; 50(11):1110. PubMed ID: 27056174
[No Abstract] [Full Text] [Related]
13. Valproate-Associated Hyperammonemic Encephalopathy: Clinical Correlates and Management Strategies in a Tertiary Care Center.
Vaidyanathan S; Chatorikar S; Praharaj SK; Munoli RN; Udupa ST
J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):145-148. PubMed ID: 36795014
[TBL] [Abstract][Full Text] [Related]
14. Valproate-induced hyperammonemic encephalopathy.
Verrotti A; Trotta D; Morgese G; Chiarelli F
Metab Brain Dis; 2002 Dec; 17(4):367-73. PubMed ID: 12602513
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of hyperammonemia in epilepsy patients with valproic acid therapy.
Kwack DW; Kim DW
Clin Neurol Neurosurg; 2023 Oct; 233():107962. PubMed ID: 37717359
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients.
Thomas KL; La AQ; Punia S; Doroudgar S; Perry PJ
Ann Clin Psychiatry; 2016 Feb; 28(1):37-42. PubMed ID: 26855984
[TBL] [Abstract][Full Text] [Related]
17. Valproate-induced hyperammonemic encephalopathy: a brief review.
Lewis C; Deshpande A; Tesar GE; Dale R
Curr Med Res Opin; 2012 Jun; 28(6):1039-42. PubMed ID: 22587482
[TBL] [Abstract][Full Text] [Related]
18. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
[TBL] [Abstract][Full Text] [Related]
19. Valproate-related hyperammonemic encephalopathy: report of 1 case.
Selvi Y; Annagur BB; Sayin AA; Akbaba N
J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
[No Abstract] [Full Text] [Related]
20. Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes.
Young L; Coffey BJ
J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):449-52. PubMed ID: 20973717
[No Abstract] [Full Text] [Related]
[Next] [New Search]